🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 135 Nanjing 4 Tianjin 3 Beijing 2 Shenzhen 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84 Clear sponsor filter
Site location
Shanghai135 Nanjing4 Tianjin3 Beijing2 Shenzhen2
All 30 locations
Target enrolment
to
135 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma
NCT06035224Clear Cell Renal Cell Carcinoma
RenJi Hospital
Phase 2
28
Shanghai
2023-08-23
Recruiting
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
NCT06972511Oligometastatic Prostate Cancer
RenJi Hospital
Phase 2/3
120
Shanghai
2023-08-20
Not yet open
Atherectomy Followed With a Drug Coated Balloon in the Treatment of Long Femoropopliteal Lesions
NCT05868564Peripheral Arterial Disease
RenJi Hospital
Not applicable
100
Shanghai
2023-07-01
Recruiting
Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients
NCT05912816Upper Urinary Tract Urothelial Carcinoma, Kidney Preservation, HER-2 ADC, PD-1antibody
RenJi Hospital
Phase 2
20
Shanghai
2023-06-10
Recruiting
Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer
NCT05910398Breast Cancer Invasive
RenJi Hospital
Phase 3
488
Shanghai
2023-06-01
Recruiting
Disitamab Vedotin (RC48-ADC) in Breast Cancer
NCT05851677Breast Cancer
RenJi Hospital
Observational
45
Shanghai
2023-06-01
Recruiting
Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions
NCT05894863Peripheral Arterial Disease
RenJi Hospital
Not applicable
120
Shanghai
2023-05-31
Recruiting
Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients
NCT05858684CAR-T Cell Therapy
RenJi Hospital
Phase EARLY_PHASE1
18
Shanghai
2023-05-11
Recruiting
RC48-ADC in HER2-low Advanced Breast Cancer
NCT05831878Advanced Breast Cancer
RenJi Hospital
Not applicable
36
Shanghai
2023-05-04
Active, closed
Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma
NCT05831891Non-clear Cell Renal Cell Carcinoma
RenJi Hospital
Phase 2
40
Shanghai
2023-05-01
Recruiting
CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer
NCT05795335Breast Cancer
RenJi Hospital
Observational
172
Shanghai
2023-04-30
Recruiting
Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure
NCT06454396Hemodialysis Access Failure
RenJi Hospital
Observational
480
Shanghai
2023-01-01
Recruiting
GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
NCT05926726Hepatocellular Carcinoma
RenJi Hospital
Not applicable
12
Shanghai
2023-01-01
Recruiting
Pre-operative Therapy in Breast Cancer
NCT05621564Breast Cancer
RenJi Hospital
Observational
6,032
Shanghai
2022-11-01
Recruiting
CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial
NCT05360290Breast Cancer, Circulating Tumor Cell
RenJi Hospital
Not applicable
484
Shanghai
2022-09-14
Recruiting
Rheolytic Thrombectomy For Acute Deep Vein Thrombosis Of Whole Lower Limb
NCT05286710Deep Vein Thrombosis
RenJi Hospital
Not applicable
160
Shanghai
2022-09-01
Recruiting
Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment
NCT05326399Liver Transplantation, Renal Insufficiency, Chronic
RenJi Hospital
Observational
369
Shanghai
2022-06-01
Recruiting
Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma
NCT05595408Muscle Invasive Upper Tract Urothelial Carcinoma
RenJi Hospital
Observational
84
Shanghai
2022-02-01
Recruiting
Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer
NCT06391190Locally Advanced Cervical Carcinoma, Concurrent Chemoradiotherapy, Immunotherapy
RenJi Hospital
Phase 1/2
20
Shanghai
2022-01-01
Recruiting
Alpha-Ketoglutarate and Abdominal Aortic Aneurysm Progression and Rupture
NCT04723888Patients With an Abdominal Aortic Aneurysm of 39-49 mm in Diameter
RenJi Hospital
Not applicable
300
Shanghai
2021-02-01
Recruiting
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932Immune System and Related Disorders
RenJi Hospital
Observational
50
Shanghai
2021-02-01
Recruiting
Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Thrombosis
NCT06124768Deep Vein Thrombosis
RenJi Hospital
Observational
210
Shanghai
2021-01-01
Recruiting
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
NCT07205510Sarcopenia, Metabolic Diseases, All-cause Mortality, Aging
RenJi Hospital
Observational
10,000
Shanghai
2020-12-01
Recruiting
Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases
NCT04229966Epidural Hematoma, Decompressive Craniectomy, Craniotomy
RenJi Hospital
Observational
2,000
Shanghai
2020-11-02
Active, closed
Prospective Randomized Evaluation of Decompressive Ipsilateral Craniectomy for Traumatic Acute Epidural Hematoma
NCT04261673Epidural Hematoma, Brain Herniation, Decompressive Craniectomy, Craniotomy
RenJi Hospital
Not applicable
120
Shanghai
2020-05-23
Recruiting
AAA-CTA Cohort Registry
NCT07039825Abdominal Aortic Aneurysm, Image
RenJi Hospital
Observational
1,000
Shanghai
2020-01-01
Recruiting
Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
NCT04254263Locally Advanced Breast Cancer
RenJi Hospital
Phase 3
316
Shanghai
2019-12-16
Active, closed
Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
NCT04126525Breast Cancer Female
RenJi Hospital
Phase 2
53
Shanghai
2019-06-18
Active, closed
Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer
NCT03982485Breast Cancer
RenJi Hospital
Phase 2
196
Shanghai
2018-10-16
Active, closed
Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer
NCT03391843Rectal Cancer Stage III
RenJi Hospital
Phase 2
100
Shanghai
2017-12-01
Recruiting
Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
NCT03392233Breast Cancer, Prostate Cancer, Non Small Cell Lung Cancer
RenJi Hospital
Phase 2
100
Shanghai
2017-08-18
Recruiting
Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
NCT03201861Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Duct Carcinoma of Breast
RenJi Hospital
Phase 3
762
Shanghai
2017-07-27
Recruiting
Early ECG Prediction of Multi-system Disease Cohort Establishment and Follow Up
NCT06924580Public Health, Public Health System Research, Multi-system Disease Diagnosis
RenJi Hospital
Observational
500,000
Shanghai
2017-01-18
Recruiting
Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disorders
NCT07450898Acute Pancreatitis (AP), Thrombotic Disorders
RenJi Hospital
Observational
10
Shanghai
2016-01-01
Active, closed
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
NCT02221999Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast Cancer
RenJi Hospital
Phase 2/3
250
Shenzhen, Handan, Hengyang, Hohhot, Kunshan, Yinchuan, Shanghai, Zhoushan
2013-09
Rows per page Showing 101–135 of 135
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.